Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Recruiting now

Conditions studied: Epidermolysis Bullosa Dystrophica

In brief

Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.

Key facts

Study ID

NCT01019148

Run by

Stanford University

People needed

70

Starts

2009-11-10

Expected to finish

2029-12-31

Last updated by the study team

2026-04-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of RDEB by local dermatologist
• 7 years of age or older

You may not qualify if…

• Medical instability limiting ability to travel to Stanford University Medical Center

Where it is running

• Stanford University School of Medicine — Stanford, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.